HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,333-1,344 of 1,979
Drug study icon
CompletedEUCTR 2005-004881-17

Efficacy and safety of agomelatine (25 mg/day with potential adjustment at 50 mg/day) given orally compared to placebo, in addition to a mood stabilizer in Bipolar I patients with a current major d...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
Bipolarity, DepressionHistorical research record
Countries
Austria, Denmark, Finland, + 3 others
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)
Drug study icon
CompletedEUCTR 2014-000456-29

EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR Bipolarity

Official study title

EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
Bipolarity, SchizophreniaHistorical research record
Countries
Czechia, Germany, Spain
Sponsor
Ferrer Internacional, S.A.
Other study type icon
CompletedNCT02874833

Exercise for Depression

Official study title

The Efficacy of Exercise in Depressive Episodes of Unipolar Depression and Bipolar Affective Disorders

This study has finished and is no longer accepting participants.

In Mainz
Depression, BipolarityInterventional studyAges 18–65
Countries
Germany
Sponsor
Johannes Gutenberg University Mainz
Other study type icon
CompletedNCT02360267

Pediatric Bipolar Registry

This study has finished and is no longer accepting participants.

In Houston
Bipolarity, Schizophrenia, ...Observational studyAges 6–17
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Biological study icon
CompletedEUCTR 2008-004857-14

The effects of erythropoietin on depressive symptoms and neurocognitive deficits in patients with treatment resistant depression and in patients with remitted Bipolarity – a proof of concept ...

Official study title

The effects of erythropoietin on depressive symptoms and neurocognitive deficits in patients with treatment resistant depression and in patients with remitted bipolar disorder – a proof of concept ...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Denmark
Depression, BipolarityHistorical research record
Countries
Denmark
Sponsor
Psykiatrisk Center Rigshospitalet
Drug study icon
Recruitment unclearEUCTR 2013-004903-37

A RANDOMIZED, 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLEXIBLE DOSE, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LURASIDONE IN CHILDREN AND ADOLESCENT SUBJECTS WITH BIPOLAR I DEPR...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Bulgaria
Bipolarity, DepressionHistorical research record
Countries
France, United Kingdom, Bulgaria, + 3 others
Sponsor
SUNOVION PHARMACEUTICALS INC.
Drug study icon
Recruitment unclearEUCTR 2021-004790-31

A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar Depression

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Poland
Bipolarity, DepressionHistorical research record
Countries
Poland, Spain
Sponsor
Janssen-Cilag International NV
Drug study icon
Recruitment unclearEUCTR 2017-000497-11

A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolarity type I Who are Early in Their Illness

Official study title

A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness

Original registry wording; source language not specified.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Austria
Bipolarity, SchizophreniaHistorical research record
Countries
Austria, Germany, Italy, + 2 others
Sponsor
Alkermes Inc
Drug study icon
Recruitment unclearEUCTR 2007-000479-40

Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with Bipolarity: searching for the antidepressant and mood stabilising neurophysiology

Official study title

Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology

Original registry wording; source language not specified.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Germany
Bipolarity, DepressionHistorical research record
Countries
Germany
Sponsor
Department of Psychiatry, RWTH Aachen

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.